期刊文献+

原发性肝癌癌旁组织生长激素受体的表达

Expressions of growth hormone receptor of para-cancerous tissues of primary hepatic carcinoma
下载PDF
导出
摘要 目的 了解原发性肝癌癌旁组织生长激素受体(GHR)的表达情况。方法 采用放射配体法对32例原发性肝癌(HCC)的癌旁组织进行了GHR的检测,并以6例正常肝组织作为对照。结果在32例肝癌癌旁组织均检测到GHR的存在,癌旁组织GHR的受体最大结合容量(R_T)值为32.7441±3.5106fmol/mg.protein,K_d为0.6109±0.1105nmol/L;与对照组肝组织相比,肝癌癌旁组织GRH的R_T降低(P<0.05),而K_d无显著性改变(P>0.05)。结论 全部癌旁组织均表达GHR,在这些受体功能未明的情况下,rhGH在肝癌患者中的使用应慎重。 Objective To investigate the expression of growth hormone receptor (GHR) in the adjacent liver tissues of hepatoeenular carcinoma (HCC). Methods 32 cases GHR of para-cancerous tissues of primory hepatic carcinoma were detected by using radioligand assays, and 6 cases of normal liver tissues were also studied as control group. Results The GHR was presented in the 32 cases of para-eaneerous tissues of liver cancer The maximal bending volume (MBV) was 32^7441±3. 5106 fmol/mg protein, and the affinity constant (Kd) was 0. 6109 ± 0. 1105 nmol/L. Comparing with the hepatic tissues of control group, the MBV of para-cancerous of liver cancer was significantly decreased (P < 0. 05), but the kd had no statistic difference (P < 0. 05) . Conclusion GHR was expressed in all samples of para-cancerous tissues with HCC. Because of their functions are not clear understood, so using rhGH should be very carefully in the HCC patients.
出处 《岭南现代临床外科》 2003年第1期55-56,共2页 Lingnan Modern Clinics in Surgery
关键词 重组人生长激素 生长激素受体 原发性肝癌 癌旁肝组织 放射配体测定 Recombinant human growth hormone Growth hormone receptor Primary hepatic carcino-ma Para-cancerous tissue Radioligand assay
  • 相关文献

参考文献4

二级参考文献9

  • 1杨冬华,刘为纹.IGF—Ⅱ,IGF—Ⅱ受体和CSF—1受体c—fms癌基因产物在肝癌,癌旁肝组…[J].中华消化杂志,1993,13(4):189-192. 被引量:25
  • 2杨冬华,徐重,杨波,顾健人,钱连方,曲淑敏.不同肝病患者肝细胞中胰岛素样生长因子及其受体的表达[J].中华医学杂志,1996,76(1):50-51. 被引量:8
  • 3Jeschke MG,Barrow RE,Herndon DN et al. Recombinant human growth hormone treatment in pediatric burn patients and its role during the hepatic acute phase response. Crit Care Med,2000,28(5):1578.
  • 4Shen XY,Holt RI,Miell JP et al. Cirrhotic liver expresses low levels of the full-length and truncated growth hormone receptors.J Clibn Endocrinol Metab,1998,83(7):2532.
  • 5Change TC,Lin JJ,Yu SC et al. Absence of growth hormone receptor in hepatocellular carcinoma and cirrhotic liver.Hepatology,1990,11(1):123.
  • 6Esposito N,Paterlini P,Kelly PA et al. Expressionof two isoforms of the human growth hormone receptor in normal liver and hepatocarcinoma. Mol Cell Endocrinol,1994,103(1-2): 13.
  • 7Amit T,Hacham H,Daily O et al. The HepG2 cell line in the study of growth hormone receptor/binding protein. Mol Cell Endocrinol,1994,101(1-2):29.
  • 8Nimer Assy,Zeev Hochberg,Rafael Enat,Yaacov Baruch. Prognostic Value of Generation of Growth Hormone-Stimulated Insulin-Like Growth Factor-I (IGF-I) and Its Binding Protein-3 in Patients with Compensated and Decompensated Liver Cirrhosis[J] 1998,Digestive Diseases and Sciences(6):1317~1321
  • 9周国雄.重组人生长激素(r-hGH)治疗慢性肝病及肝硬化的研究进展[J].国外医学(消化系疾病分册),1999,19(3):155-158. 被引量:20

共引文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部